| John Marcus Facciani, MD | |
|
426 W Main St, Salem, VA 24153-3610 | |
| (540) 855-5100 | |
| Not Available |
| Full Name | John Marcus Facciani |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 25 Years |
| Location | 426 W Main St, Salem, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417951989 | NPI | - | NPPES |
| 010070074 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 0101236001 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vistar Eye Center Inc | 0446249858 | 25 |
News Archive
Scientists have found that sperm DNA from the testicles of many infertile men is as good as that of ejaculated sperm of fertile men. This may explain a major cause of male infertility and opens the possibility of using sperm taken directly from the testicles of these men; to overcome their infertility
The first large-scale study testing all the DNA—the entire genome—of tumour cells from more than 400 women with advanced breast cancer has identified individuals with a good chance of benefiting from specific treatments already being tested in clinical trials.
No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.
The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one spontaneous preterm birth.
› Verified 3 days ago
| Entity Name | Vistar Eye Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457323545 PECOS PAC ID: 0446249858 Enrollment ID: O20040511001643 |
News Archive
Scientists have found that sperm DNA from the testicles of many infertile men is as good as that of ejaculated sperm of fertile men. This may explain a major cause of male infertility and opens the possibility of using sperm taken directly from the testicles of these men; to overcome their infertility
The first large-scale study testing all the DNA—the entire genome—of tumour cells from more than 400 women with advanced breast cancer has identified individuals with a good chance of benefiting from specific treatments already being tested in clinical trials.
No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.
The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one spontaneous preterm birth.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Marcus Facciani, MD Po Box 1789, Roanoke, VA 24008-1789 Ph: (540) 855-5100 | John Marcus Facciani, MD 426 W Main St, Salem, VA 24153-3610 Ph: (540) 855-5100 |
News Archive
Scientists have found that sperm DNA from the testicles of many infertile men is as good as that of ejaculated sperm of fertile men. This may explain a major cause of male infertility and opens the possibility of using sperm taken directly from the testicles of these men; to overcome their infertility
The first large-scale study testing all the DNA—the entire genome—of tumour cells from more than 400 women with advanced breast cancer has identified individuals with a good chance of benefiting from specific treatments already being tested in clinical trials.
No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.
The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one spontaneous preterm birth.
› Verified 3 days ago
Dr. David A Kinsler, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 426 W Main St, Salem, VA 24153 Phone: 540-344-4000 | |
Dr. Richard Johnson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1802 Braeburn Dr, Salem, VA 24153 Phone: 540-772-3480 Fax: 540-772-3779 | |
Dr. David Andrew Eliason, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Eye Clinic 112-e, Va Medical Center, Salem, VA 24153 Phone: 540-982-2463 | |
Will Dickson Griffeth, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 426 W Main St, Salem, VA 24153 Phone: 540-855-3554 Fax: 540-342-4373 | |
Dr. George Walton Riddick Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Salem Veterans Affairs Medical Center, 1970 Roanoke Boulevard, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-224-1922 | |
Dr. Eric Lee Peterson, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 426 W Main St, Salem, VA 24153 Phone: 540-855-5100 Fax: 540-387-3349 |